Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

Covid19

18Nov

City-Data Forum

Posted by: admin Categories: Covid19
Comments Off on City-Data Forum

Please register to participate in our discussions with 2 million other members – it’s free and quick! Some forums can only be seen by registered members. After you create your account, you’ll be able to customize options and access all our 15,000 new posts/day with fewer ads. City-Data Forum Message […]

Read more
18Nov

remdesivir resistance | This Week in Virology

Posted by: admin Categories: Covid19
Comments Off on remdesivir resistance | This Week in Virology

TWiV explains that a recent report suggesting that the SARS-CoV-2 spike protein inhibits V(D)J recombination in vitro would not impact immunity after infection or vaccination, and describes the isolation of remdesivir resistant mutants in cells in culture, and the emergence of amino acid changes in the spike protein identical to those in variants of concern, […]

Read more
17Nov

Celltrion bags European approval for COVID-19 antibody treatment | 2021-11-16

Posted by: admin Categories: Covid19
Comments Off on Celltrion bags European approval for COVID-19 antibody treatment | 2021-11-16

Celltrion Inc.’s Regkirona (regdanvimab), a monoclonal antibody treatment for COVID-19, received its latest approval from the European Commission (EC), making it the first Mab developed in South Korea to be approved there. The green light for Celltrion Healthcare Hungary Kft., the Hungarian arm of Korean biopharmaceutical company Celltrion, is for the treatment of adults with […]

Read more
16Nov

In vitro activity of itraconazole against SARS-CoV-2. | J Med Virol;93(7): 4454-4460, 2021 Jul.

Posted by: admin Categories: Covid19
Comments Off on In vitro activity of itraconazole against SARS-CoV-2. | J Med Virol;93(7): 4454-4460, 2021 Jul.

ABSTRACT Although vaccination campaigns are currently being rolled out to prevent coronavirus disease (COVID-19), antivirals will remain an important adjunct to vaccination. Antivirals against coronaviruses do not exist, hence global drug repurposing efforts have been carried out to identify agents that may provide clinical benefit to patients with COVID-19. Itraconazole, an antifungal agent, has been […]

Read more
13Nov

First coronavirus mutation resistant to antiviral drug remdesivir discovered

Posted by: admin Categories: Covid19
Comments Off on First coronavirus mutation resistant to antiviral drug remdesivir discovered

A group of scientists has discovered the first covid-19 mutation resistant to the antiviral drug remdesivir, according to a study posted this week on the medRxiv prepress server. The researchers presented the case of a immunosuppressed patient in his 70s suffering from cancer. The woman contracted COVID-19 in May 2020 and was treated with remdesivir. […]

Read more
13Nov

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients

Posted by: admin Categories: Covid19
Comments Off on Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients

Background: The effectiveness of the best combination between different antiviral and anti-inflammatory drugs stills an interest in the treatment of COVID19 infection. Patients and methods: A prospective randomized cohort study comprised 108 adult patients with confirmed PCR COVID 19 infection with systemic hyper inflammation state, divided into two groups according to the treatment regimen, 56 […]

Read more
13Nov

Remdesivir | SpringerLink

Posted by: admin Categories: Covid19
Comments Off on Remdesivir | SpringerLink

In a report, four patients were reported, out of which three patients (13.5-year-old patient, 10-year-old girl and 3-month-old infant) [not all sexes stated] were described, who developed sinus bradycardia during treatment with remdesivir for COVID-19 pneumonia [routes and dosages not stated and duration of treatments to reactions onset not stated]. All three patients were presented […]

Read more
12Nov

Research digest.pdf – Remdesivir for the Treatment of Covid-19 u2014 Final Report J.H Beigel K.M Tomashek L.E Dodd A.K Mehta B.S Zingman A.C Kalil E

Posted by: admin Categories: Covid19
Comments Off on Research digest.pdf – Remdesivir for the Treatment of Covid-19 u2014 Final Report J.H Beigel K.M Tomashek L.E Dodd A.K Mehta B.S Zingman A.C Kalil E

Remdesivir for the Treatment of Covid-19 — Final Report J.H. Beigel, K.M. Tomashek, L.E. Dodd, A.K. Mehta, B.S. Zingman, A.C. Kalil, E. Hohmann, H.Y. Chu, A. Luetkemeyer, S. Kline, D. Lopez de Castilla, R.W. Finberg, K. Dierberg, V. Tapson, L. Hsieh, T.F. Patterson, R. Paredes, D.A. Sweeney, W.R. Short, G. Touloumi, D.C. Lye, N. Ohmagari, […]

Read more
12Nov

CHMP recommends EU approval of casirivimab and imdevimab to treat and prevent COVID-19 infection.

Posted by: admin Categories: Covid19
Comments Off on CHMP recommends EU approval of casirivimab and imdevimab to treat and prevent COVID-19 infection.

The positive opinion is for people aged 12 years and older for the treatment of non-hospitalized patients (outpatients) with confirmed COVID-19 who do not require oxygen supplementation and who are at increased risk of progressing to severe COVID-19, and to prevent COVID-19. A final decision from the European Commission regarding the approval of the antibody […]

Read more
11Nov

Remdesivir-Linked Covid-19 Mutation Found In Immunocompromised Patient, Researchers Find

Posted by: admin Categories: Covid19
Comments Off on Remdesivir-Linked Covid-19 Mutation Found In Immunocompromised Patient, Researchers Find

Top Line Coronavirus mutations that confer resistance to the antiviral drug remdesivir were found in an immunocompromised patient who had previously been treated with the drug, researchers have found, leading to a higher incidence of COVID-19 in patients with persistent disease. raises concerns about the possible emergence of drug-resistant versions. , – Advertisement – Remdesivir […]

Read more
4Nov

WHO’s Papowitz: Vaccination remains only solution

Posted by: admin Categories: Covid19
Comments Off on WHO’s Papowitz: Vaccination remains only solution

Thursday, November 4, 2021 WHO Romania crisis manager Heather Papowitz recommends a plan in the context of the COVID-19 pandemic in Romania, with clear objectives and elements, at the same time, saying that vaccination is the only solution. The WHO representative has been for two weeks in Romania and has met representatives of family doctors, […]

Read more
28Oct

New COVID-19 Variant Can Evade Vaccine-Induced Antibodies, Reveals Study

Posted by: admin Categories: Covid19
Comments Off on New COVID-19 Variant Can Evade Vaccine-Induced Antibodies, Reveals Study

A rare COVID-19 variant that has been detected in multiple patients across Angola and Sweden during Spring 2021 may be extremely successful at evading vaccine-induced antibodies, suggests a recent study published in Nature Molecular and Cellular Immunology. First detected in Tanzania in February, the A.30 variant may pose a distinct threat in a world becoming increasingly reliant on vaccines to protect against […]

Read more
27Oct

Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study

Posted by: admin Categories: Covid19
Comments Off on Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study

Objectives: Remdesivir is one of the most widely recommended and used medications for COVID-19 treatment. However, different outcomes have been reported for hospitalized patients with COVID-19 treated with remdesivir. Specifically, the effect of the timing of remdesivir initiation (from patient’s symptom onset) on clinical outcomes in COVID-19 patients has not been investigated. Methods: This is […]

Read more
26Oct

REMDESIVIR

Posted by: admin Categories: Covid19
Comments Off on REMDESIVIR

异名/同义词 2-ETHYLBUTYL (2S)-2-(((2R, 3S, 4R, 5R)-5-(4-AMINOPYRROLO(2,1-F) (1,2,4)TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL) METHOXY)(PHENOXY) PHOSPHORYL) AMINO) PROPANOATE2-ETHYLBUTYL (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE2-ETHYLBUTYL N-((S)-(2-C-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-2,5-ANHYDRO-D-ALTRONONITRIL-6-O-YL)PHENOXYPHOSPHORYL)-L-ALANINATEGS-5734L-ALANINE, N-((S)-HYDROXYPHENOXYPHOSPHINYL)-, 2-ETHYLBUTYL ESTER, 6-ESTER WITH 2-C-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-2,5-ANHYDRO-D-ALTRONONITRILEREMDESIVIRREMDESIVIR [USAN]REMDESIVIR [WHO-DD]VEKLURY Source link

Read more
24Oct

Bamlanivimab | SpringerLink

Posted by: admin Categories: Covid19
Comments Off on Bamlanivimab | SpringerLink

A 69-year-old woman developed transfusion-related acute lung injury following off-label treatment with bamlanivimab for COVID-19Footnote 1 . The woman presented to the hospital due to fevers, nausea, generalised weakness, vomiting and dyspnoea. Her test showed positive result for COVID-19 infection. Thus, she started receiving off-label treatment with bamlanivimab [banlamivimab; dosage not stated] infusion. Approximately 45 minutes […]

Read more
24Oct

Nanoviricides Platform Technology based NV-387 polymer Protects Remdesivir from Plasma-Mediated Catabolism in vitro:Importance of its increased lifetime for in vivo action

Posted by: admin Categories: Covid19
Comments Off on Nanoviricides Platform Technology based NV-387 polymer Protects Remdesivir from Plasma-Mediated Catabolism in vitro:Importance of its increased lifetime for in vivo action

%PDF-1.4 % 117 0 obj > endobj 129 0 obj >stream 2021-10-21T17:30:50Z 2021-10-23T23:59:14-07:00 2021-10-23T23:59:14-07:00 application/pdf Nanoviricides Platform Technology based NV-387 polymer Protects Remdesivir from Plasma-Mediated Catabolism in vitro:Importance of its increased lifetime for in vivo action uuid:41209fdc-1dd2-11b2-0a00-4308275dc400 uuid:41209fdf-1dd2-11b2-0a00-810000000000 endstream endobj 5 0 obj > endobj 2 0 obj > endobj 47 0 obj > endobj 79 […]

Read more
22Oct

Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study | Renal Replacement Therapy

Posted by: admin Categories: Covid19
Comments Off on Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study | Renal Replacement Therapy

Subjects and data Surveillance of new cases of COVID-19 in dialysis facilities in Japan was initiated by the COVID-19 Task Force Committee of the Japanese Association of Dialysis Physicians, the Japanese Society for Dialysis Therapy, and the Japanese Society of Nephrology on April 8, 2020 [3]. This registry was used to collect data of dialysis […]

Read more
22Oct

Sujok: A therapy seeking recognition

Posted by: admin Categories: Covid19
Comments Off on Sujok: A therapy seeking recognition

The Sujok therapy became popular in some parts of India among people suffering from chronic diseases after delivering promising results Medical experts are always busy inventing new medicines and procedures for the rapidly proliferating new diseases across the world. However, a large number of diseases still elude modern medical science. The Covid-19 pandemic proved that […]

Read more
« Older posts
Newer posts »